# K200314: Capere Thrombectomy System

- Pathway: 510(k) (Special)
- Applicant: Vascular Medcure, Inc.
- Decided: Mar 4, 2020 after 27 days
- Product code: QEW (Peripheral Mechanical Thrombectomy With Aspiration)
- Device class: 2
- Regulation: 21 CFR 870.5150
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K832023 (1983). 18 ancestors in all.
1 later device descends from it; 1 cites it directly.
3 of 20 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K180722: CAPERE Thrombectomy System, Kp Medcure, Inc. (2018) Summary page 4.

## Most influential descendants
- K203476: CAPERE Thrombectomy System (2020), 0 descendants of its own

## Indications for use
The CAPERE® Thrombectomy System is indicated for: • Non-surgical removal of soft emboli and thrombi from blood vessels. • Injection, infusion and/or aspiration of contrast media and other fluids into blood vessel. The CAPERE® Thrombectomy System is intended only for use in the peripheral vasculature and is not intended for use in the pulmonary arteries.

Source page: https://510kreport.com/device/K200314
Methodology: https://510kreport.com/methodology